261Y000161/13559 - MOMELOTINIB 100 MG COMP REV
About This Opportunity
TranslatedThis tender, identified as 261Y000161/13559, pertains to the procurement of Momelotinib in a dosage of 100 mg. Momelotinib is a medication used primarily in the treatment of certain types of cancer, specifically targeting hematological malignancies. The tender seeks suppliers who can provide this pharmaceutical product in compliance with the relevant regulatory standards. Key requirements for bidders may include the ability to demonstrate quality assurance processes, adherence to Good Manufacturing Practices (GMP), and the provision of necessary documentation to ensure the product's efficacy and safety. Additionally, suppliers must be capable of timely delivery to specified healthcare facilities. The procurement is likely to take place within a specific geographical region, although the exact location has not been detailed in the provided information. Interested parties should prepare to submit their proposals, ensuring that they meet all outlined criteria and deadlines. This tender represents an important opportunity for pharmaceutical companies to contribute to the healthcare sector by supplying essential medications that support patient treatment regimens.
This is a supplies contract in the health and medical services, information and communication technology and Monitoring Evaluation sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 74,783.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "261Y000161/13559 - Momeletinib 100 MG Comp Rev" pertains to the procurement of Momeletinib, a pharmaceutical product specified at a dosage of 100 mg. This tender is issued in Portugal, reflecting the country's ongoing efforts to enhance its healthcare system through the acquisition of essential medical supplies. The contracting authority for this procurement is not explicitly stated; however, it is likely to involve a public health entity or government agency responsible for managing pharmaceutical supplies within the Portuguese mainland or its autonomous regions.
This tender invites bids from qualified suppliers capable of providing Momeletinib in compliance with regulatory standards. Typical requirements for such pharmaceutical tenders include the presentation of relevant certifications, proof of the supplier's ability to meet quality assurance protocols, and adherence to local and international pharmaceutical regulations. Bidders are also expected to demonstrate their capacity for timely delivery, ensuring that the required quantities are supplied as per the stipulated timelines.
Prospective suppliers should prepare to submit comprehensive documentation detailing their product specifications, pricing structures, and any previous experience in supplying similar medications to public health institutions. Furthermore, transparency in pricing and the assurance of consistent supply will be critical factors in the evaluation process. Overall, this tender represents a significant opportunity for suppliers in the pharmaceutical sector to contribute to the healthcare needs of Portugal, ensuring the availability of essential medications to improve patient outcomes.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 19, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Santa Maria, E. P. E.
Unidade Local de Saúde de Santa Maria, E. P. E. has issued 1,315 procurement notices on BidsFactory, including 3 currently open and 1,293 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to GLAXOSMITHKLINE - PRODUTOS FARMACÊUTICOS, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Santa Maria, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €74,783. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.